Both This medication and Mounjaro represent innovative strategies to treating blood sugar levels, and increasingly, obesity. Tirzepatide is a dual agonist that targets several hormones involved in glucose regulation: this peptide and GIP. This medication, often viewed as a trade name for Semaglut